We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




First-in-Class Diagnostic Blood Test Detects Axial Spondyloarthritis

By LabMedica International staff writers
Posted on 07 May 2025

Axial spondyloarthritis (axSpA) is a chronic inflammatory autoimmune condition that typically affects individuals during their most productive years, with symptoms often emerging before the age of 45. More...

Diagnosing axSpA is challenging, with a common delay of 7-10 years between the onset of symptoms and a confirmed diagnosis. The disease frequently presents as persistent chronic back pain, which can be easily overlooked as a symptom of axSpA. Without proper treatment, axSpA can lead to debilitating complications, including irreversible spinal fusion that severely impairs mobility and quality of life. Consequently, there is an urgent need to shorten the diagnostic delay for this condition. A newly developed, first-in-class diagnostic blood test for axSpA now offers physicians an objective tool that aids in diagnosis, helping to reduce delays and improve patient outcomes in managing this debilitating disease.

The SPINEstat test, developed by Augurex Life Sciences (Vancouver, Canada), identifies auto-antibodies against the 14-3-3eta protein, providing a clinically validated and objective biomarker for early and accurate axSpA diagnosis. When combined with CRP (C-reactive protein), this test can identify 90% of axSpA cases, thereby enhancing diagnostic accuracy. It is especially valuable for patients who test negative for traditional markers, such as HLA-B27.

SPINEstat provides healthcare professionals with a crucial tool for distinguishing axSpA from other causes of chronic back pain, filling a significant gap in diagnostic capabilities. By supplementing traditional imaging with this diagnostic support, SPINEstat enables more informed, evidence-based decisions, leading to quicker and more appropriate treatment plans. The test has been approved by Health Canada as a Class II medical device, offering a new and valuable resource in the diagnosis of axSpA.

“Health Canada’s approval of SPINEstat marks a major step forward in axSpA diagnostics, and we are very proud that patients in Canada, and soon around the world, can benefit from this major advancement,” said Neil Klompas, CEO of Augurex. “By providing physicians with an objective tool to aid in diagnosis, Augurex is helping to decrease diagnostic delays and improve patient outcomes in this debilitating disease.”

Related Links:
Augurex Life Sciences


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Silver Member
Luteinizing Hormone Test
Luteinizing Hormone (LH) Rapid Test
New
Respiratory Syncytial Virus Test
OSOM® RSV Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The POC device rapidly predicts neonatal respiratory disease at birth in the NICU (Photo courtesy of SIME Diagnostics)

AI-Powered Lung Maturity Test Identifies Newborns at Higher Risk of Respiratory Distress

Each year, approximately 300,000 babies in the United States are born between 32 and 36 weeks' gestation, according to national health data. This group is at an elevated risk for respiratory distress,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: Custom hardware and software for the real-time detection of immune cell biophysical signatures in NICU (Photo courtesy of Pediatric Research, DOI:10.1038/s41390-025-03952-y)

First-Of-Its-Kind Device Profiles Newborns' Immune Function Using Single Blood Drop

Premature infants are highly susceptible to severe and life-threatening conditions, such as sepsis and necrotizing enterocolitis (NEC). Newborn sepsis, which is a bloodstream infection occurring in the... Read more

Pathology

view channel
Image: Results of AI-based 3D virtual H&E staining and quantitative analysis of pathological tissue (Photo courtesy of Nature Communications, DOI:10.1038/s41467-025-59820-0)

Virtual Staining Technology Paves Way for Non-Invasive Pathological Diagnosis

For more than 200 years, traditional pathology has depended on the technique of examining cancer tissues under a microscope, a method that provides only limited, specific cross-sections of the 3D structure... Read more

Technology

view channel
Image: Concept of biosensor integrated into hygiene pads enabling direct semi-quantitative analysis of biomarkers in unprocessed menstruation blood (Photo courtesy of Dosnon, L et al. DOI: 10.1002/advs.202505170)

First Ever Technology Recognizes Disease Biomarkers Directly in Menstrual Blood in Sanitary Towels

Over 1.8 billion people menstruate worldwide, yet menstrual blood has been largely overlooked in medical practice. This blood contains hundreds of proteins, many of which correlate with their concentration... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.